Business Economy


Laurus Labs net profit jumps 300 pc to Rs 92 crore in Q3FY25

Hyderabad, Jan 24 (UNI) Laurus Labs Ltd., a leading research and development-driven pharmaceutical and biotech company in India, on Friday reported a net profit of Rs 92 crore in Q3FY25, a 300 percent increase from Rs 23 crores in the previous year.
Revenue from operations rose 18 percent to Rs 1,415 crore during the quarter as compared to Rs 1,195 crore in the corresponding period in the previous year, Hyderabad-based pharma company said in a release here.
However, for the nine months in FY25, the net profit rose 47 percent to Rs 125 crore as against Rs 85 crore in 9MFY24 while the revenues increased 6 percent to Rs 3,834 crore compared to the year-ago period.
Commenting on the company’s performance, Dr. Satyanarayana Chava, Founder & Chief Executive Officer said “The quarter witnessed robust growth in the CDMO and FDF division, partially offset by soft API performance. Healthy commercial execution is our top priority and our performance is well on track with revenues accelerating in Q4”.
Based on our continued progress across diverse portfolio and pipeline projects I remain confident about our long-term future, and I acknowledge the focus and commitment of our team in making Laurus better positioned to deliver value to all stakeholder in coming years, he added.
V V Ravi Kumar, Executive Director & Chief Financial Officer commented; “We are pleased to report healthy progress for the quarter; we delivered ₹ 1,415 Cr in revenues, strong growth of 18 percent, and ₹ 285 crore EBITDA grew by 56 percent, resulting in 20.1 percent margin. Gross margins remained healthy at 56.9 percent due to favorable CDMO mix and process optimization measures. The fundamentals of our business remain healthy, driven by order book position and continued progress in CDMO projects”.
Our 9M performance remained on track, with revenues reaching ₹ 3,834 crore, representing 6 percent growth and EBITDA stood at ₹ 638 crore, marking a growth of 18 percent. We reaffirm our Full-year growth outlook, driven by scheduled CDMO project deliveries. Our capital allocation strategy remains unchanged, prioritizing investments into high value CMO/CDMO opportunities to drive near and long-term growth, he added.
UNI KNR BD
More News

Fake FAG ball and wheel bearing seized in raid

18 Nov 2025 | 1:54 AM

Chennai, Nov 17 (UNI) In an effort to prevent counterfeiting of its products Schaeffler India officials and law enforcement agencies carried out a raid in five locations in Delhi and seized counterfeit FAG wheel bearings and other FAG ball bearings along with fake packaging materials.

see more..

AP Minister highlights India’s manufacturing potential

18 Nov 2025 | 1:02 AM

Vijayawada, Nov 17 (UNI) Reiterating the government’s commitment to strengthening the manufacturing ecosystem, Kondapalli Srinivas, Minister MSME, highlighted that India—traditionally strong in the services sector—must now expand its presence in global manufacturing value chains.

see more..

NPCIL and Maharashtra Govt ink MOU to set up nuclear power plants

17 Nov 2025 | 11:23 PM

Chennai, Nov 17 (UNI) Nuclear Power Corporation of India Ltd (NPCIL) on Monday signed a Memorandum of Understanding (MoU) with Maharashtra State Power Generation Company (MAHAGENCO) and Maharashtra Institution for Transformation (MITRA) to explore possibilities of cooperation in co-development of nuclear-based power generation plants in the western state.

see more..

Market finishes higher for sixth consecutive session; Nifty closed above 26,000 mark

17 Nov 2025 | 10:01 PM

New Delhi, Nov 17 (UNI) The stock market on Monday started the week on a strong note, finishing higher for the sixth consecutive session.

see more..

Artha Bharat in talks with five investment management teams

17 Nov 2025 | 9:52 PM

Chennai, Nov 17 (UNI) Artha Bharat Investment Managers IFSC LLP, licensed by the International Financial Services Centres Authority (IFSCA) to offer its platform to third-party fund managers.
With assets under management (AUM) exceeding Rs.7,000 crore (over $800 million), Artha Bharat is already in advanced discussions with five independent investment management teams who plan to use its platform to launch funds ranging from $5 million to $50 million, the company said.

see more..